Woburn drug maker may stop making sterile injections

outterson_white-new_65wBoston Globe (subscription required)
Kevin Outterson, School of Law

The owner of a Woburn specialty pharmacy that recalled two dozen drugs after the discovery of ­unidentified contaminants told regulators Tuesday that he was uncertain whether he would continue mixing sterile injectable medications and eye solutions, the riskiest kind of compounded drugs…

View full article